At Asphalion, we are dedicating this week to delving into the field of CMC, starting today with a success case we have prepared where Asphalion helped a biopharmaceutical company with the preparation of an EU IMPD for a biologic product that had started Phase I of a clinical trial in the European Union.
Thanks to our extensive track record of over 20 years, at Asphalion we can assist you in selecting the optimal strategy, optimizing costs and enhancing time-to-market, as well as with all other kind of activities and projects.
CASE STUDY ANALYSIS: Preparation of an EU IMPD for a biologic product
For further information you can contact us at: [email protected]
